Bausch Health Companies (BHC) Other Accumulated Expenses (2009 - 2012)
Bausch Health Companies' (BHC) quarterly Other Accumulated Expenses came in at $16.3 million in Q4 2012, down 66.11% year-on-year from $48.0 million in Q1 2012, and down 66.11% quarter-over-quarter from $48.0 million in Q4 2011.
Bausch Health Companies (BHC) Other Accumulated Expenses (2009 - 2012) Analysis & Trends
Bausch Health Companies has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $16.3 million for Q4 2012.
- Other Accumulated Expenses for Q4 2012 came in at $16.3 million, down 66.11% year-over-year; the trailing twelve-month figure through Dec 2012 was $16.3 million (down 66.11% YoY), and the FY2012 annual result was $16.3 million, down 66.11% from the prior year.
- Other Accumulated Expenses came in at $16.3 million for Q4 2012 at Bausch Health Companies, down from $48.0 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $48.0 million in Q4 2011 to a low of $2.0 million in Q2 2010.
- The 4-year median for Other Accumulated Expenses is $16.1 million (2010), against an average of $21.8 million.
- Across the five-year window, Other Accumulated Expenses soared 200.21% in 2011 and slumped 66.11% in 2012, its largest moves.
- Bausch Health Companies' Other Accumulated Expenses stood at $8.0 million in 2009, then surged by 101.26% to $16.0 million in 2010, then jumped by 200.21% to $48.0 million in 2011, then plunged by 66.11% to $16.3 million in 2012.
- The last three Other Accumulated Expenses figures came in at $16.3 million (Q4 2012), $48.0 million (Q4 2011), and $16.0 million (Q4 2010), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 16.28 Mn |
| Dec 31, 2011 | 48.03 Mn |
| Dec 31, 2010 | 16.00 Mn |
| Sep 30, 2010 | 40.50 Mn |
| Jun 30, 2010 | 2.00 Mn |
| Dec 31, 2009 | 7.95 Mn |